Literature DB >> 12353608

Comparison of an 'intuitive' NHS hearing aid prescription method with DSL 4.1 targets for amplification.

Jonathan O Parsons1, Charles R Clark.   

Abstract

This study aimed to evaluate current practice in a National Health Service Trust in setting hearing aid output to meet amplification targets prescribed by desired sensation level (DSL) using a range of NHS hearing aids. A consecutive sample of 33 patients was drawn from the hearing aid waiting list of the Royal Devon & Exeter Hospital (RD&E). The age range was 33-83 years. Patients not giving written consent and those with complex hearing losses were excluded. At review, pure-tone audiogram, uncomfortable loudness levels, real-ear coupler difference, user gain and maximum output were recorded. Data were entered into DSL 4.1 prescription software. Wilcoxon tests were used to compare the measured user gain and maximum output with DSL 4.1-generated targets. The results demonstrate significant differences (p<0.05) at 0.25, 0.5, 0.75, 1.5, 2, 3, 4 and 6 kHz between target and measured values for user gain. This study reveals that the routine intuitive method for prescribing hearing aids at the RD&E is not effective in meeting targets for amplified speech as prescribed by DSL.

Entities:  

Mesh:

Year:  2002        PMID: 12353608     DOI: 10.3109/14992020209090410

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  2 in total

Review 1.  Comparative studies on hearing aid selection and fitting procedures: a review of the literature.

Authors:  Mick Metselaar; Bert Maat; Hans Verschuure; Wouter A Dreschler; Louw Feenstra
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-23       Impact factor: 2.503

Review 2.  The Desired Sensation Level multistage input/output algorithm.

Authors:  Susan Scollie; Richard Seewald; Leonard Cornelisse; Sheila Moodie; Marlene Bagatto; Diana Laurnagaray; Steve Beaulac; John Pumford
Journal:  Trends Amplif       Date:  2005
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.